Xeloda Vs Monitoring in Advanced Colorectal Cancer Responsive to Chemotherapy


NCT00189683

Interventional

Phase 3

Unknown status
To compare maintenance chemotherapy with Xeloda to control after best response with first line chemotherapy in advanced colorectal cancer. Main endpoint is progression free survival. A total of 300 patients will be included.
Jan 01,1970
All
18 Years
N/A

In order to facilitate the use of our website, we use cookies.

Please confirm if you accept our tracking cookies. When declining the cookies, you can continue visiting the website without sending data to third party services. Read our complete cookie statement here.